Current, Former US FDA Advisory Committee Members' Reform Idea: Allow Conflicted Experts

Conflicted experts should be allowed to participate as nonvoting members and panels should take a benefit-risk vote on product-specific applications, the majority of respondents said in a survey conducted by 3D Communications.